Page last updated: 2024-11-06

morpholinopropane sulfonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-(N-morpholino)propanesulfonic acid : A Good's buffer substance, pKa = 7.2 at 20 degreeC. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID70807
CHEMBL ID1234443
CHEBI ID44115
SCHEMBL ID15732
SCHEMBL ID6449440
MeSH IDM0052498

Synonyms (82)

Synonym
AKOS005542400
CHEMBL1234443
4-morpholinepropanesulfonic acid
3-n-morpholinopropanesulfonic acid
brn 1106776
4-morpholinopropanesulphonic acid
einecs 214-478-5
4-morpholinepropane sulfonic acid
3[n-morpholino]propane sulfonic acid
inchi=1/c7h15no4s/c9-13(10,11)7-1-2-8-3-5-12-6-4-8/h1-7h2,(h,9,10,11
mops, bioperformance certified, cell culture tested, >=99.5% (titration)
mops, bioxtra, >=99.5% (titration)
mops, >=99.5% (titration)
mops ,
3-morpholinopropanesulfonic acid
3-(n-morpholino)propanesulfonic acid
CHEBI:44115 ,
morpholinopropane sulfonic acid
1132-61-2
3-morpholin-4-ylpropane-1-sulfonic acid
2AXI
DB03434
M-8500
mops, bioultra, >=99.5% (t)
M0707
BMSE000788
BMSE000893
M02085
273bp63nv3 ,
unii-273bp63nv3
dtxsid4044371 ,
cas-1132-61-2
dtxcid2024371
tox21_302146
NCGC00255922-01
BBL010801
3-(morpholin-4-yl)propane-1-sulfonic acid
STK606781
mops, 3-(n-morpholino)propanesulfonic acid
FT-0613840
mops [mi]
BP-20546
3-morpholinopropane-1-sulfonic acid ,
SCHEMBL15732
3-[n-morpholino] propane sulfonic acid
SCHEMBL6449440
4-morpholinopropanesulfonic acid
3-(4-morpholinyl)-1-propanesulfonic acid #
3-(4-morpholino)propanesulfonic acid
3-(4-morpholino)propanesulfonicacid
HMS3604E12
mfcd00006183
morpholinopropanesulfonic acid; was 15
mops, bioultra, for molecular biology, >=99.5% (t)
mops, >=99.0%
HY-D0859
mops, biochemical grade
mops, vetec(tm) reagent grade
mops, p.a., 99%
mops, anhydrous, free-flowing, redi-dri(tm), >=99.5%
SY010930
BCP05573
CS-0015169
Q4030654
4-chloro-3-[(methylamino)sulfonyl]benzoicacid
AS-13603
EN300-53406
3-(n-morpholino)propanesulphonic acid
gamma-(n-morpholino)propanesulphonic acid (mops)
mops ultra pure grade 100g
gamma-(n-morpholino)propanesulfonic acid (mops)
gamma-n-morpholino-propanesulphonic-acid-mops
P19612
3-(n-morpholino)propane sulfonic acid (mops)
3-(n-morpholino)propane sulfonic acid; mops
mops, free acid
PB39633
3-morpholinopropanesulfonic acid; 3-(n-morpholino)propanesulfonic acid; 4-morpholinepropanesulfonic acid; mops
mops solution
mfcd11100867
3-(morpholin-4-yl)propane-1-sulfonic acid (mops)
Z123738220

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" 7 These data show that five of the most commonly used artificial buffers, to study muscles in vitro, exert adverse effects on contractility of arterial and venous smooth muscle."( Adverse effects of artificial buffers on contractile responses of arterial and venous smooth muscle.
Altura, BM; Altura, BT; Carella, A; Turlapaty, PD, 1980
)
0.26
" To establish safe environmental regulation it is important to properly define the relationship between pH and metal toxicity, a process that involves manipulating the pH of test water in the lab."( Implications of pH manipulation methods for metal toxicity: not all acidic environments are created equal.
Brix, KV; Esbaugh, AJ; Grosell, M; Mager, EM; Santore, R, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
MOPSAn oxygen molecular entity that acts as an excellent buffer for many biological systems at near-neutral pH.
MOPSAn oxygen molecular entity that acts as an excellent buffer for many biological systems at near-neutral pH.
organosulfonic acidAn organic derivative of sulfonic acid in which the sulfo group is linked directly to carbon.
morpholinesAny compound containing morpholine as part of its structure.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Sulfur Metabolism (Propanesulfonate)2834

Research

Studies (89)

TimeframeStudies, This Drug (%)All Drugs %
pre-199023 (25.84)18.7374
1990's20 (22.47)18.2507
2000's24 (26.97)29.6817
2010's18 (20.22)24.3611
2020's4 (4.49)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.10 (24.57)
Research Supply Index4.55 (2.92)
Research Growth Index4.50 (4.65)
Search Engine Demand Index35.70 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.08%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other92 (98.92%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]